Literature DB >> 12403127

IL-13 suppresses MUC5AC gene expression and mucin secretion in nasal epithelial cells.

Chang-Hoon Kim1, Kyoung Seob Song, Ja Seok Koo, Hyun-Ung Kim, Jae Young Cho, Hyun Jun Kim, Joo-Heon Yoon.   

Abstract

Recently, it was found that IL-13 is involved in allergic inflammation and mucus hypersecretion in in vivo animal models. However, the role of IL-13 in in vitro cellular models has yet to be determined. This study aimed to investigate the direct effect of IL-13 on mucin gene expression and mucin secretion in cultured normal human nasal epithelial cells. After treatment with IL-13, total mucin and MUC5AC mucin levels were measured using an immunoblotting assay. MUC2, MUC5AC and MUC8 mRNA expression were determined using reverse transcription-polymerase chain reaction. Also, immunostaining was performed using a MUC5AC antibody on histologic and cytospin slides. After treatment with > or = 5 ng/ml IL-13, the level of total mucin and MUC5AC mucin secretion decreased substantially. The expression of MUC2 and MUC8 mRNA increased with higher concentrations of IL-13, but the expression of MUC5AC mRNA decreased. On the 7th day after IL-13 treatment, a significant decrease in the number of MUC5AC-positive cells was confirmed by immunostaining. These findings indicate that IL-13 suppresses MUC5AC mucin gene expression and mucin secretion in cultured normal human nasal epithelial cells in vitro.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12403127     DOI: 10.1080/000164802320396321

Source DB:  PubMed          Journal:  Acta Otolaryngol        ISSN: 0001-6489            Impact factor:   1.494


  11 in total

1.  Differential regulation of MUC5AC/Muc5ac and hCLCA-1/mGob-5 expression in airway epithelium.

Authors:  Philip Thai; Yin Chen; Gregory Dolganov; Reen Wu
Journal:  Am J Respir Cell Mol Biol       Date:  2005-09-08       Impact factor: 6.914

Review 2.  Mucin overproduction in chronic inflammatory lung disease.

Authors:  Hans-Peter Hauber; Susan C Foley; Qutayba Hamid
Journal:  Can Respir J       Date:  2006-09       Impact factor: 2.409

3.  Roles and regulation of the mucus barrier in the gut.

Authors:  Steve Cornick; Adelaide Tawiah; Kris Chadee
Journal:  Tissue Barriers       Date:  2015-04-03

4.  Decrease in airway mucous gene expression caused by treatment with anti-tumor necrosis factor alpha in a murine model of allergic asthma.

Authors:  Paula J Busse; Teng Fei Zhang; Brian Schofield; Saikiran Kilaru; Sangita Patil; Xiu-Min Li
Journal:  Ann Allergy Asthma Immunol       Date:  2009-10       Impact factor: 6.347

5.  Plantamajoside Inhibits Lipopolysaccharide-Induced MUC5AC Expression and Inflammation through Suppressing the PI3K/Akt and NF-κB Signaling Pathways in Human Airway Epithelial Cells.

Authors:  Chaonan Ma; Wei Ma
Journal:  Inflammation       Date:  2018-06       Impact factor: 4.092

6.  Effect of proinflammatory cytokines on the human MUC5AC promoter activity in vitro and in vivo.

Authors:  I-Jong Wang; Chun-Yin Wu; Fung-Rong Hu
Journal:  Clin Ophthalmol       Date:  2007-03

7.  Thiolated chitosan nanoparticles enhance anti-inflammatory effects of intranasally delivered theophylline.

Authors:  Dong-Won Lee; Shawna A Shirley; Richard F Lockey; Shyam S Mohapatra
Journal:  Respir Res       Date:  2006-08-24

8.  IL-4 induced MUC4 enhancement in respiratory epithelial cells in vitro is mediated through JAK-3 selective signaling.

Authors:  Gautam Damera; Baoyun Xia; Goverdhan P Sachdev
Journal:  Respir Res       Date:  2006-03-21

9.  Nasal epithelial cells can act as a physiological surrogate for paediatric asthma studies.

Authors:  Surendran Thavagnanam; Jeremy C Parker; Michael E McBrien; Grzegorz Skibinski; Michael D Shields; Liam G Heaney
Journal:  PLoS One       Date:  2014-01-27       Impact factor: 3.240

Review 10.  Mucins Dynamics in Physiological and Pathological Conditions.

Authors:  Hassan Melhem; Daniel Regan-Komito; Jan Hendrik Niess
Journal:  Int J Mol Sci       Date:  2021-12-20       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.